Disclosure 0001636282-26-000119-1

SEC FORM 4

$419,528.50

Spyre Therapeutics, Inc. (SYRE)

Acquisition (code M) of 28,933 shares at $14.50 per share.

Reporting Person King-Jones Heidy · Officer Title See Remarks · Transaction Code M

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001636282-26-000119 · filed 2026-10-02 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Spyre Therapeutics, Inc. (SYRE)." Disclosed 2026-10-02. https://desqlong.com/cards/0001636282-26-000119-1 (retrieved 2026-10-03).